MA
Mansi Aggarwal
About Mansi Aggarwal
Data last updated:
Mansi Aggarwal is a Director at Wuze Pharmaceuticals Private Limited (since 2022), Director at Comece International Private Limited (since 2025) and Director at Wuze International Private Limited (since 2025). The companies operate in E-Commerce. The largest current company by reported revenue is Wuze Pharmaceuticals Private Limited at ₹3.94 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Aug 2022 | 2018 | ₹3.94 Cr (FY 2025) | Active | |
| Director | 04 Jun 2025 | 2025 | Active | ||
| Director | 12 Mar 2025 | 2025 | Active |
Board colleagues of Mansi Aggarwal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Praveen Kumar Singla | 08053528 | Wuze Pharmaceuticals Private Limited , Wuze International Private Limited | Director |
| Deepanshu Aggarwal | 11423746 | Comece International Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mansi Aggarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mansi Aggarwal
Mansi Aggarwal currently holds 3 directorships: Wuze Pharmaceuticals Private Limited (Director, since 01 Aug 2022, revenue ₹3.94 Cr (FY 2025)); Comece International Private Limited (Director, since 04 Jun 2025); Wuze International Private Limited (Director, since 12 Mar 2025).
Mansi Aggarwal was first appointed on 01 Aug 2022 as Director at Wuze Pharmaceuticals Private Limited. The most recent appointment on record is 04 Jun 2025 at Comece International Private Limited.
The current boards of Mansi Aggarwal's companies include Praveen Kumar Singla (Wuze Pharmaceuticals Private Limited), Deepanshu Aggarwal (Comece International Private Limited).